Cite

HARVARD Citation

    Doyen, J. et al. (n.d.). OC-0480: Five-year clinical outcome of the Phase III ACCORD 12 neoadjuvant trial in rectal cancer. Radiotherapy and oncology. pp. S230-. [Online]. 
  
Back to record